Journal of Yeungnam Medical Science
- Volume 28 Issue 2
- /
- Pages.133-144
- /
- 2011
- /
- 2799-8010(eISSN)
Tigecycline Treatment for Infections Caused by Multidrug-Resistant Pathogens
다약제내성 균주 감염에 대한 Tigecycline의 치료
- Lee, Mi-Jung (Department of Internal Medicine, Daegu Fatima Hospital) ;
- Seo, A-Young (Department of Internal Medicine, Daegu Fatima Hospital) ;
- Bae, Sang-Soo (Department of Internal Medicine, Daegu Fatima Hospital) ;
- Jeong, Dong-Hyong (Department of Internal Medicine, Daegu Fatima Hospital) ;
- Yoon, Kyung-Hwa (Department of Internal Medicine, Daegu Fatima Hospital) ;
- Hwang, Byung-Sik (Department of Internal Medicine, Daegu Fatima Hospital) ;
- Kang, Sung-Hoon (Department of Internal Medicine, Daegu Fatima Hospital) ;
- Oh, Dae-Myung (Department of Internal Medicine, Daegu Fatima Hospital) ;
- Kwon, Ki-Tae (Department of Internal Medicine, Daegu Fatima Hospital) ;
- Lee, Shin-Won (Department of Internal Medicine, Daegu Fatima Hospital) ;
- Song, Do-Young (Department of Laboratory Medicine, Daegu Fatima Hospital)
- 이미정 (대구파티마병원 내과) ;
- 서아영 (대구파티마병원 내과) ;
- 배상수 (대구파티마병원 내과) ;
- 정동형 (대구파티마병원 내과) ;
- 윤경화 (대구파티마병원 내과) ;
- 황병식 (대구파티마병원 내과) ;
- 강성훈 (대구파티마병원 내과) ;
- 오대명 (대구파티마병원 내과) ;
- 권기태 (대구파티마병원 내과) ;
- 이신원 (대구파티마병원 내과) ;
- 송도영 (대구파티마병원 진단검사의학과)
- Published : 2011.12.30
Abstract
Background: Tigecycline (TIG), a new broad-spectrum glycylcycline with anti-multidrug-resistant-(MDR)-pathogen activity, was launched in March 2009 in South Korea, but there are insufficient clinical studies on its use in the country. As such, this study was performed to analyze cases of severe MDR-pathogen-caused infections treated with TIG. Methods: Patients treated with TIG within the period from May 2009 to June 2010 were enrolled in this study. Their clinical and microbiologic data were reviewed retrospectively. Results: Twenty-one patients were treated with TIG for complicated skin and soft-tissue infections (cSSTIs) (42.9%), complicated intra-abdominal infections (cIAIs) (38.1%), or pneumonia (19.1%) caused by MDR pathogens like carbapenem-resistant